Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Confirmed diagnosis of Breast Cancer with at least one breast cancer-related bone lesion
No treatment with bisphosphonates within 6 months prior to inclusion into the study
Good health status (ECOG Performance status 0-2)
You may not be if
Patients who do not have at least one breast cancer-related bone lesion that is detectable on conventional radiographs of bone (plain film) at screening
Abnormal renal function
History of diseases with influence on bone metabolism such as Paget's disease and primary hyperparathyroidism
Pregnancy and lactation
Current active dental problems including infection of the teeth or jawbone (maxilla or mandibular); dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw (ONJ), of exposed bone in the mouth, or of slow healing after dental procedures, recent (within 6 weeks) or planned dental or jaw surgery (e.g..extraction, implants)
Clareo Health | Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions
